A second, silent pandemic is emerging while we focus our efforts on COVID-19. Antimicrobial resistance (AMR) threatens millions of lives by making infections more difficult to treat and prevent. This presentation discusses the potential impact of COVID-19 on AMR and its main driver, antibiotic use. Two rapid reviews will be presented evaluating 1) bacterial co-infections and 2) antibiotic prescribing in patients with COVID-19. Antibiotic stewardship in the context of COVID-19 will also be discussed.
The objectives of the webinar are to:
Explain the potential implications of COVID-19 to antimicrobial resistance.
Discuss rapid review findings on bacterial infection and antimicrobial prescribing in patients with COVID-19.
Discuss antibiotic stewardship strategies at the patient and population level.
Presenters names: Valerie Leung and Bradley Langford
The presentation can be found here: [ Ссылка ]
